LA

Linaben Ashokbhai Jambucha

Active Director Designated Partner DIN 07987737
DIN 07987737 First appointment Aug 2017 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Linaben Ashokbhai Jambucha

Data last updated:

Linaben Ashokbhai Jambucha is a Designated Partner at Genomesense Institute Of Molecular Medicine Llp (since 2017). The company operates in Research & Development.

DIN 07987737
Primary Designation Designated Partner
Industry Research & Development
First Appointment 31 Aug 2017
Oldest Company Age 11 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner31 Aug 20172015Active

Board colleagues of Linaben Ashokbhai Jambucha

Directorship timeline

Open interactive timeline →
Genomesense Institute Of Molecular Medicine Llp
Premium access

Shareholding and investment profile for Linaben Ashokbhai Jambucha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Linaben Ashokbhai Jambucha

Linaben Ashokbhai Jambucha currently holds 1 directorship: Genomesense Institute Of Molecular Medicine Llp (Designated Partner, since 31 Aug 2017).

Linaben Ashokbhai Jambucha was first appointed on 31 Aug 2017 as Designated Partner at Genomesense Institute Of Molecular Medicine Llp.

The current boards of Linaben Ashokbhai Jambucha's companies include Kutbddin Husenibhai Cinemawala (Genomesense Institute Of Molecular Medicine Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available